Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F8N6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,951
Award facts
- Contract value 100% obligated
- $13,950.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 21, 2026, the Defense Logistics Agency awarded a delivery order valued at $13,950.80 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which is not set-aside for any specific business category, represents a child contract under AmerisourceBergen's parent company Cencora, Inc. The contract will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of January 22, 2026. This delivery order falls under the broader pharmaceutical procurement framework managed by the Defense Logistics Agency's Troop Support Medical division, which oversees medical supply chain operations for military and federal healthcare systems.
The delivery order is executed under Cencora's substantial indefinite delivery contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC authorizes the supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Repatha, a PCSK9 inhibitor used in cardiovascular disease management, represents the type of specialty pharmaceutical product delivered through this vehicle to military treatment facilities and federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F8N6P?
SPE2DR26F8N6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F8N6P worth?
The government has obligated $13,951 on SPE2DR26F8N6P.
Is contract SPE2DR26F8N6P an order under another contract?
Yes. SPE2DR26F8N6P is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N6P competed?
The extent of competition for SPE2DR26F8N6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award